A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Phase 1 / Phase 2 · 65 sites
Search the registry
2,585 studies found
Phase 1 / Phase 2 · 65 sites
Phase 1 / Phase 2 · 21 sites
Phase 1 / Phase 2 · 6 sites
Phase 1 · 3 sites
Phase 3 · 227 sites
Potential match only. Final eligibility is determined by the study team.